BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

UK’s First AI Tool to Predict Hospital Infections Secures CE Mark, MHRA Approval

AI tool that spots hospital infections up to 72 hours early, newly backed by former health minister Lord Bethell, Prof Carole Longson and Dr Ar...

August 06, 2025 | News

Innovent Biologics gets FDA nod to begin Phase 1 trials of oral GLP-1R agonist IBI3032

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

August 05, 2025 | News

METiS Technologies Secures RMB 400 Million in Series D Funding to Advance AI-Powered Nanodelivery and Accelerate CGT Innovation

METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series...

August 05, 2025 | News

Fighting Dengue in a Changing Climate: Takeda’s Vision for Resilient Health Systems in Emerging Markets

Dengue is no longer a seasonal threat. It is a growing climate-driven crisis. With rising global temperatures, shifting rainfall patterns and rapid urbanis...

August 04, 2025 | Expert Insight

Energenesis Completes Phase I Trial of ENERGI-F705PD, a Novel Oral Therapy for Parkinson’s Disease

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pha...

August 04, 2025 | News

VB Spine Expands Globally with Acquisition of Stryker’s Spinal Implants Business in Australia and New Zealand

Stryker’s spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor...

August 01, 2025 | News

Quanterix Launches First-to-Market p‑Tau 205 and 212 Assays, Expanding Alzheimer’s Biomarker Portfolio

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, announced the first to market, com...

August 01, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)

Johor’s Healthcare & Life Sciences Investment Boom (2022–2025) Over the past three years, the southern Malaysian state of Johor has emerge...

July 30, 2025 | Report

Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals

Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...

July 28, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

July 25, 2025 | News

Clearwater Partners with Google Cloud to Supercharge Healthcare Cybersecurity with Real-Time Threat Intelligence

Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for the healthcare industry, today announced a collaboration with Goog...

July 25, 2025 | News

iMedX Gains Health NZ Endorsement for AI Scribe Trial Across Public Health Services

iMedX is proud to announce its formal endorsement by Health New Zealand | Te Whatu Ora as one of only two Ambient AI Scribe tools approved for trialling wi...

July 24, 2025 | News

Global Call for Self-Care Integration as World Faces NCD Crisis

On International Self-Care Day, and as world leaders prepare for a landmark United Nations General Assembly meeting on non-communicable diseases (NCDs) thi...

July 24, 2025 | News

Stay Connected